Citadel Advisors’s Evaxion A/S EVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-26
Closed -$891 14779
2023
Q4
$891 Buy
+26
New +$1.04K ﹤0.01% 13921
2023
Q2
Sell
-24
Closed -$1.36K 14551
2023
Q1
$1.36K Buy
24
+14
+140% +$1.02K ﹤0.01% 14322
2022
Q4
$900 Sell
10
-2,760
-100% -$323K ﹤0.01% 14563
2022
Q3
$364K Buy
2,770
+2,024
+271% +$255K ﹤0.01% 9150
2022
Q2
$73K Buy
746
+496
+198% +$56.7K ﹤0.01% 11671
2022
Q1
$38K Sell
250
-28
-10% -$4.61K ﹤0.01% 12967
2021
Q4
$61K Buy
+278
New +$86.3K ﹤0.01% 13128

Other funds holding EVAX

Citadel Advisors's EVAX Position: Q1 2026 in Review

Citadel Advisors opened a new position in Evaxion A/S (EVAX) in Q1 2026: 17,773 shares worth $66.1K. The stake represents ﹤0.01% of the portfolio and ranks #12284 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in EVAX as recently as Q3 2024.

Citadel Advisors first reported a position in EVAX in Q1 2022 and has held it in 8 quarters since. The position peaked at $281K in Q3 2022. 17 funds tracked by Wall St. Rank hold EVAX as of Q1 2026.

  • Citadel Advisors held 17,773 shares of Evaxion A/S worth $66.1K as of Q1 2026.
  • Evaxion A/S was a new Citadel Advisors position in Q1 2026.
  • Evaxion A/S made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12284 holding.
  • Citadel Advisors first reported a position in Evaxion A/S in Q1 2022 and has held it in 8 quarters since.
  • Citadel Advisors's Evaxion A/S position peaked at $281K in Q3 2022.
  • 17 funds tracked by Wall St. Rank held Evaxion A/S as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.